DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 10 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $540,000 | -50.7% | 144,800 | -47.0% | 0.20% | -46.7% |
| Q3 2021 | $1,095,000 | -56.9% | 273,100 | -52.1% | 0.38% | -50.1% |
| Q2 2021 | $2,539,000 | -51.4% | 570,500 | 0.0% | 0.77% | -56.6% |
| Q1 2021 | $5,220,000 | -9.9% | 570,500 | -0.2% | 1.77% | -23.8% |
| Q4 2020 | $5,795,000 | +139.2% | 571,500 | 0.0% | 2.32% | +108.4% |
| Q3 2020 | $2,423,000 | -0.4% | 571,500 | +62.8% | 1.11% | -20.5% |
| Q2 2020 | $2,433,000 | +147.5% | 351,100 | 0.0% | 1.40% | +55.4% |
| Q1 2020 | $983,000 | -25.6% | 351,100 | +28.9% | 0.90% | +31.0% |
| Q4 2019 | $1,321,000 | +134.2% | 272,400 | 0.0% | 0.69% | +121.9% |
| Q3 2019 | $564,000 | -57.5% | 272,400 | +1.9% | 0.31% | -49.9% |
| Q2 2019 | $1,326,000 | +92.7% | 267,300 | +76.4% | 0.62% | +89.3% |
| Q1 2019 | $688,000 | +18.2% | 151,500 | -24.2% | 0.33% | +9.0% |
| Q4 2018 | $582,000 | – | 200,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,146,470 | $4,861,000 | 5.06% |
| Corriente Advisors, LLC | 730,000 | $3,095,000 | 1.57% |
| Manatuck Hill Partners, LLC | 571,500 | $2,423,000 | 1.11% |
| CVI Holdings, LLC | 276,176 | $1,171,000 | 0.48% |
| DAFNA Capital Management LLC | 156,529 | $664,000 | 0.22% |
| Worth Venture Partners, LLC | 42,887 | $182,000 | 0.15% |
| Granite Point Capital Management, L.P. | 646,855 | $2,743,000 | 0.15% |
| Ikarian Capital, LLC | 415,000 | $1,759,000 | 0.13% |
| Maven Securities LTD | 359,285 | $1,473,000 | 0.12% |
| Nantahala Capital Management | 756,193 | $3,206,000 | 0.10% |